• A study to test the safety and effects of TLN-372 alone and with other cancer drugs in patients with advanced solid tumors with KRAS gene changes

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study of ivonescimab alone or with ligufalimab versus pembrolizumab for patients with recurrent or metastatic head and neck squamous cell cancer

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Spain

  • Testing the Safety and Effectiveness of CTH120 Compared to Placebo in Adult Men with Fragile X Syndrome

    Recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • A study comparing venetoclax, azacitidine, and quizartinib versus venetoclax and azacitidine in newly diagnosed acute myeloid leukemia patients not suitable for standard chemotherapy

    Recruiting

    3 1 1
    Investigated drugs:
    Spain

  • A Study of Autologous Urothelial Cell Treatment with Bioprinter During Bladder Reconstruction Surgery in Patients with Muscle-Invasive Bladder Cancer

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Greece

  • A Study of Povetacicept Compared to Tacrolimus for Adults with Primary Membranous Nephropathy

    Recruiting

    4 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Germany Hungary Ireland Italy The Netherlands +1

  • A Study of Ferric Carboxymaltose to Improve Exercise Ability in Patients with Pulmonary Hypertension and Iron Deficiency

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium

  • Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

    Recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Bulgaria Czechia Denmark France +11

  • A study of RO7268489 added to ocrelizumab compared to placebo in adults with progressive multiple sclerosis

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Hungary Italy Poland Portugal +1

  • A Study of SAB-142 to Slow the Progression of Type 1 Diabetes in Adults and Children Recently Diagnosed with the Disease

    Recruiting

    2 1 1
    Investigated drugs:
    Austria Belgium Denmark Finland France Germany +5

powered by